nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenylpyraline—Bifonazole—Letrozole—breast cancer	0.33	0.343	CrCrCtD
Diphenylpyraline—Diphemanil Methylsulfate—Tamoxifen—breast cancer	0.122	0.127	CrCrCtD
Diphenylpyraline—Cloperastine—Raloxifene—breast cancer	0.0833	0.0863	CrCrCtD
Diphenylpyraline—Phenoxybenzamine—Toremifene—breast cancer	0.0577	0.0598	CrCrCtD
Diphenylpyraline—Bromodiphenhydramine—Toremifene—breast cancer	0.0514	0.0533	CrCrCtD
Diphenylpyraline—Orphenadrine—Toremifene—breast cancer	0.0404	0.0419	CrCrCtD
Diphenylpyraline—Benzphetamine—Toremifene—breast cancer	0.0404	0.0419	CrCrCtD
Diphenylpyraline—Benzyl Benzoate—Toremifene—breast cancer	0.0374	0.0388	CrCrCtD
Diphenylpyraline—Phenoxybenzamine—Tamoxifen—breast cancer	0.0363	0.0376	CrCrCtD
Diphenylpyraline—Diphenhydramine—Toremifene—breast cancer	0.0359	0.0372	CrCrCtD
Diphenylpyraline—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0323	0.0335	CrCrCtD
Diphenylpyraline—Benzphetamine—Tamoxifen—breast cancer	0.0254	0.0263	CrCrCtD
Diphenylpyraline—Orphenadrine—Tamoxifen—breast cancer	0.0254	0.0263	CrCrCtD
Diphenylpyraline—Benzyl Benzoate—Tamoxifen—breast cancer	0.0235	0.0244	CrCrCtD
Diphenylpyraline—Diphenhydramine—Tamoxifen—breast cancer	0.0225	0.0234	CrCrCtD
Diphenylpyraline—Bifonazole—CYP17A1—breast cancer	0.000595	0.144	CrCbGaD
Diphenylpyraline—Trimethaphan—BCHE—breast cancer	0.000416	0.101	CrCbGaD
Diphenylpyraline—Bifonazole—CYP19A1—breast cancer	0.000303	0.0735	CrCbGaD
Diphenylpyraline—Orphenadrine—SCN10A—breast cancer	0.000233	0.0565	CrCbGaD
Diphenylpyraline—Reboxetine—CYP2D6—breast cancer	0.000233	0.0565	CrCbGaD
Diphenylpyraline—Trospium—CYP2D6—breast cancer	0.000228	0.0554	CrCbGaD
Diphenylpyraline—Reboxetine—CYP3A4—breast cancer	0.0002	0.0484	CrCbGaD
Diphenylpyraline—Reboxetine—ABCB1—breast cancer	0.000166	0.0403	CrCbGaD
Diphenylpyraline—Benzatropine—CYP2D6—breast cancer	0.000147	0.0357	CrCbGaD
Diphenylpyraline—Bifonazole—CYP3A4—breast cancer	0.000142	0.0345	CrCbGaD
Diphenylpyraline—Cinnarizine—CYP1A1—breast cancer	0.000142	0.0344	CrCbGaD
Diphenylpyraline—Bepridil—CYP2D6—breast cancer	0.000116	0.0281	CrCbGaD
Diphenylpyraline—Diphenhydramine—PTGS1—breast cancer	0.000111	0.027	CrCbGaD
Diphenylpyraline—Cinnarizine—CYP2D6—breast cancer	0.000105	0.0256	CrCbGaD
Diphenylpyraline—Atomoxetine—CYP2D6—breast cancer	9.37e-05	0.0227	CrCbGaD
Diphenylpyraline—Modafinil—CYP3A4—breast cancer	9.34e-05	0.0227	CrCbGaD
Diphenylpyraline—Mianserin—CYP2D6—breast cancer	9.16e-05	0.0222	CrCbGaD
Diphenylpyraline—Fentanyl—CYP3A4—breast cancer	9.14e-05	0.0222	CrCbGaD
Diphenylpyraline—Bepridil—ABCB1—breast cancer	8.27e-05	0.0201	CrCbGaD
Diphenylpyraline—Benzphetamine—CYP3A4—breast cancer	8.1e-05	0.0197	CrCbGaD
Diphenylpyraline—Atomoxetine—CYP3A4—breast cancer	8.04e-05	0.0195	CrCbGaD
Diphenylpyraline—Mianserin—CYP3A4—breast cancer	7.86e-05	0.0191	CrCbGaD
Diphenylpyraline—Phenoxybenzamine—CYP3A4—breast cancer	7.74e-05	0.0188	CrCbGaD
Diphenylpyraline—Fentanyl—ABCB1—breast cancer	7.61e-05	0.0185	CrCbGaD
Diphenylpyraline—Diphenhydramine—CYP2D6—breast cancer	7.57e-05	0.0184	CrCbGaD
Diphenylpyraline—Orphenadrine—CYP3A4—breast cancer	6.14e-05	0.0149	CrCbGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	5.13e-05	0.00165	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	5.13e-05	0.00165	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—WNT1—breast cancer	5.02e-05	0.00161	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—BRAF—breast cancer	4.92e-05	0.00158	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC2A2—breast cancer	4.9e-05	0.00157	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ABCG2—breast cancer	4.8e-05	0.00154	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PTGER1—breast cancer	4.77e-05	0.00153	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PDE2A—breast cancer	4.69e-05	0.0015	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCL27—breast cancer	4.69e-05	0.0015	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL3—breast cancer	4.69e-05	0.0015	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	4.64e-05	0.00149	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL2—breast cancer	4.59e-05	0.00147	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—AGTR2—breast cancer	4.59e-05	0.00147	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—PTHLH—breast cancer	4.54e-05	0.00146	CbGpPWpGaD
Diphenylpyraline—HRH1—IL-4 Signaling Pathway—AKT1—breast cancer	4.49e-05	0.00144	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—EDNRB—breast cancer	4.4e-05	0.00141	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—WNT10B—breast cancer	4.37e-05	0.0014	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—TFRC—breast cancer	4.28e-05	0.00137	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL3—breast cancer	4.25e-05	0.00137	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCL27—breast cancer	4.25e-05	0.00137	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PDE2A—breast cancer	4.25e-05	0.00137	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—MDM2—breast cancer	4.13e-05	0.00132	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—NCOA2—breast cancer	4.12e-05	0.00132	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—RAF1—breast cancer	4.11e-05	0.00132	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CALCA—breast cancer	4e-05	0.00128	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.93e-05	0.00126	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL12—breast cancer	3.91e-05	0.00125	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCR4—breast cancer	3.91e-05	0.00125	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.79e-05	0.00122	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—BRAF—breast cancer	3.77e-05	0.00121	CbGpPWpGaD
Diphenylpyraline—SLC6A3—NRF2 pathway—TGFB1—breast cancer	3.7e-05	0.00119	CbGpPWpGaD
Diphenylpyraline—SLC6A3—SLC-mediated transmembrane transport—ALB—breast cancer	3.69e-05	0.00118	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—AGTR1—breast cancer	3.53e-05	0.00113	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—NCOA1—breast cancer	3.47e-05	0.00111	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—RGS2—breast cancer	3.43e-05	0.0011	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CCL20—breast cancer	3.39e-05	0.00109	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—PLG—breast cancer	3.38e-05	0.00108	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LGR6—breast cancer	3.32e-05	0.00106	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCDC88C—breast cancer	3.32e-05	0.00106	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—LPAR1—breast cancer	3.28e-05	0.00105	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GPER1—breast cancer	3.16e-05	0.00102	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SFRP1—breast cancer	3.16e-05	0.00102	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—MDM2—breast cancer	3.16e-05	0.00101	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—RAF1—breast cancer	3.15e-05	0.00101	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—HMOX1—breast cancer	3.12e-05	0.001	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—RGS2—breast cancer	3.11e-05	0.000998	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PDE4D—breast cancer	3.1e-05	0.000994	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CCL20—breast cancer	3.08e-05	0.000987	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	3.06e-05	0.000982	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NMBR—breast cancer	3.03e-05	0.000973	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CNR2—breast cancer	3.02e-05	0.000969	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ABCB1—breast cancer	2.99e-05	0.000961	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—LPAR1—breast cancer	2.98e-05	0.000956	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CUL5—breast cancer	2.82e-05	0.000905	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PTGER1—breast cancer	2.82e-05	0.000905	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HEYL—breast cancer	2.82e-05	0.000905	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PDE4D—breast cancer	2.81e-05	0.000903	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CNR2—breast cancer	2.74e-05	0.00088	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RSPO3—breast cancer	2.65e-05	0.000851	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL2—breast cancer	2.6e-05	0.000833	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AGTR2—breast cancer	2.6e-05	0.000833	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—WNT10B—breast cancer	2.58e-05	0.000827	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—WWOX—breast cancer	2.58e-05	0.000827	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—WNT1—breast cancer	2.58e-05	0.000827	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PTHLH—breast cancer	2.57e-05	0.000824	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—INHBB—breast cancer	2.51e-05	0.000806	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDE2A—breast cancer	2.51e-05	0.000806	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCL27—breast cancer	2.51e-05	0.000806	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL3—breast cancer	2.51e-05	0.000806	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—EDNRB—breast cancer	2.49e-05	0.000798	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BMPR2—breast cancer	2.4e-05	0.000769	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DLL4—breast cancer	2.4e-05	0.000769	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AGTR2—breast cancer	2.36e-05	0.000756	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL2—breast cancer	2.36e-05	0.000756	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PTHLH—breast cancer	2.33e-05	0.000748	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CDH5—breast cancer	2.3e-05	0.000737	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmission across Chemical Synapses—HRAS—breast cancer	2.26e-05	0.000726	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CALCA—breast cancer	2.26e-05	0.000725	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—EDNRB—breast cancer	2.26e-05	0.000724	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SFRP2—breast cancer	2.25e-05	0.000723	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRLR—breast cancer	2.21e-05	0.00071	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL12—breast cancer	2.21e-05	0.000708	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCR4—breast cancer	2.21e-05	0.000708	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	2.21e-05	0.000708	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GLI2—breast cancer	2.14e-05	0.000686	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VCP—breast cancer	2.14e-05	0.000686	CbGpPWpGaD
Diphenylpyraline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	2.13e-05	0.000682	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LEPR—breast cancer	2.1e-05	0.000675	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	2.1e-05	0.000673	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CALCA—breast cancer	2.05e-05	0.000658	CbGpPWpGaD
Diphenylpyraline—HRH1—G alpha (q) signalling events—PIK3CA—breast cancer	2.04e-05	0.000653	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCR4—breast cancer	2e-05	0.000643	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL12—breast cancer	2e-05	0.000643	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AGTR1—breast cancer	2e-05	0.00064	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	1.98e-05	0.000636	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ARHGDIA—breast cancer	1.95e-05	0.000627	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FST—breast cancer	1.9e-05	0.000611	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HEY2—breast cancer	1.88e-05	0.000604	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—ALB—breast cancer	1.87e-05	0.000601	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RPS6KB2—breast cancer	1.86e-05	0.000596	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RGS2—breast cancer	1.84e-05	0.00059	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	1.82e-05	0.000584	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCL20—breast cancer	1.82e-05	0.000583	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AGTR1—breast cancer	1.81e-05	0.000582	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—ITPR1—breast cancer	1.79e-05	0.000575	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TLE3—breast cancer	1.76e-05	0.000565	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LPAR1—breast cancer	1.76e-05	0.000565	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HEY1—breast cancer	1.74e-05	0.000559	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Neuronal System—HRAS—breast cancer	1.73e-05	0.000557	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DLL1—breast cancer	1.71e-05	0.000548	CbGpPWpGaD
Diphenylpyraline—SLC6A3—Transmembrane transport of small molecules—RAF1—breast cancer	1.69e-05	0.000543	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	1.68e-05	0.000541	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HIST1H2BK—breast cancer	1.68e-05	0.000538	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HIST1H2BC—breast cancer	1.68e-05	0.000538	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GRB7—breast cancer	1.66e-05	0.000533	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDE4D—breast cancer	1.66e-05	0.000533	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CSF2—breast cancer	1.65e-05	0.000531	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TAB2—breast cancer	1.63e-05	0.000524	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—ITPR1—breast cancer	1.63e-05	0.000522	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CNR2—breast cancer	1.62e-05	0.00052	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR ligand binding—CXCL8—breast cancer	1.62e-05	0.000519	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—MMP3—breast cancer	1.62e-05	0.000518	CbGpPWpGaD
Diphenylpyraline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	1.61e-05	0.000517	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—DKK1—breast cancer	1.58e-05	0.000507	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VEGFC—breast cancer	1.57e-05	0.000503	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JAG2—breast cancer	1.55e-05	0.000496	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—WNT1—breast cancer	1.52e-05	0.000489	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PLA2G4A—breast cancer	1.52e-05	0.000487	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CSF2—breast cancer	1.5e-05	0.000482	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NOTCH4—breast cancer	1.44e-05	0.000463	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—GZMB—breast cancer	1.43e-05	0.00046	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AGTR2—breast cancer	1.39e-05	0.000447	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL2—breast cancer	1.39e-05	0.000447	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PTHLH—breast cancer	1.38e-05	0.000442	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BMP2—breast cancer	1.38e-05	0.000442	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EDNRB—breast cancer	1.33e-05	0.000428	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PGR—breast cancer	1.32e-05	0.000424	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—THBS1—breast cancer	1.31e-05	0.000421	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FLT1—breast cancer	1.25e-05	0.000402	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF3—breast cancer	1.25e-05	0.000401	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SQSTM1—breast cancer	1.25e-05	0.000401	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	1.24e-05	0.000399	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JAG1—breast cancer	1.23e-05	0.000395	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NOTCH3—breast cancer	1.23e-05	0.000394	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PARP1—breast cancer	1.23e-05	0.000394	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CALCA—breast cancer	1.21e-05	0.000389	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RPS6—breast cancer	1.2e-05	0.000384	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF4—breast cancer	1.19e-05	0.000381	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL12—breast cancer	1.18e-05	0.00038	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCR4—breast cancer	1.18e-05	0.00038	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PAK1—breast cancer	1.16e-05	0.000373	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TCF7L2—breast cancer	1.14e-05	0.000366	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AKT2—breast cancer	1.14e-05	0.000365	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CG—breast cancer	1.13e-05	0.000362	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HSP90AA1—breast cancer	1.1e-05	0.000353	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NOTCH2—breast cancer	1.1e-05	0.000353	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	1.09e-05	0.00035	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AGTR1—breast cancer	1.07e-05	0.000344	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PRL—breast cancer	1.07e-05	0.000344	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ADAM10—breast cancer	1.06e-05	0.000339	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—STK11—breast cancer	1.06e-05	0.000339	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PLG—breast cancer	1.04e-05	0.000335	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AKT2—breast cancer	1.03e-05	0.000331	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF10—breast cancer	1.03e-05	0.000329	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CD—breast cancer	9.92e-06	0.000318	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PDGFA—breast cancer	9.91e-06	0.000318	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TGFBR2—breast cancer	9.77e-06	0.000313	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ITPR1—breast cancer	9.61e-06	0.000308	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ERBB4—breast cancer	9.55e-06	0.000306	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—STAT5A—breast cancer	9.55e-06	0.000306	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MMP3—breast cancer	9.55e-06	0.000306	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	9.52e-06	0.000305	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SMAD4—breast cancer	9.24e-06	0.000297	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IGF1R—breast cancer	9.19e-06	0.000295	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—CXCL8—breast cancer	9.15e-06	0.000293	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HES1—breast cancer	9.03e-06	0.00029	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NCOR1—breast cancer	8.97e-06	0.000288	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PLA2G4A—breast cancer	8.97e-06	0.000288	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CSF2—breast cancer	8.87e-06	0.000285	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGF1—breast cancer	8.87e-06	0.000285	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—RAF1—breast cancer	8.85e-06	0.000284	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NRG1—breast cancer	8.81e-06	0.000283	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—H2AFX—breast cancer	8.75e-06	0.000281	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—IL2—breast cancer	8.74e-06	0.00028	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—E2F1—breast cancer	8.68e-06	0.000279	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CB—breast cancer	8.64e-06	0.000277	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SPP1—breast cancer	8.34e-06	0.000268	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—CXCL8—breast cancer	8.31e-06	0.000266	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ERBB3—breast cancer	8.25e-06	0.000265	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGFR2—breast cancer	8.24e-06	0.000264	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—IL2—breast cancer	7.94e-06	0.000255	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TERT—breast cancer	7.91e-06	0.000254	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FGFR1—breast cancer	7.68e-06	0.000246	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HIF1A—breast cancer	7.56e-06	0.000243	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—LEP—breast cancer	7.38e-06	0.000237	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CAV1—breast cancer	7.32e-06	0.000235	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—KDR—breast cancer	7.23e-06	0.000232	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ESR1—breast cancer	7.05e-06	0.000226	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—FN1—breast cancer	6.96e-06	0.000223	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NFKBIA—breast cancer	6.88e-06	0.000221	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NOTCH1—breast cancer	6.81e-06	0.000219	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CG—breast cancer	6.66e-06	0.000214	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—KIT—breast cancer	6.66e-06	0.000214	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—APC—breast cancer	6.66e-06	0.000214	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EGF—breast cancer	6.59e-06	0.000211	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—MAPK3—breast cancer	6.38e-06	0.000205	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—BRAF—breast cancer	6.26e-06	0.000201	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IGF1—breast cancer	6.1e-06	0.000196	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AKT2—breast cancer	6.1e-06	0.000196	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—EGFR—breast cancer	6.07e-06	0.000195	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CD—breast cancer	5.86e-06	0.000188	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	5.8e-06	0.000186	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SERPINE1—breast cancer	5.79e-06	0.000186	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—KRAS—breast cancer	5.74e-06	0.000184	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—NOS3—breast cancer	5.53e-06	0.000177	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—PIK3CA—breast cancer	5.27e-06	0.000169	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MDM2—breast cancer	5.25e-06	0.000168	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RAF1—breast cancer	5.23e-06	0.000168	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—RELA—breast cancer	5.21e-06	0.000167	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—ERBB2—breast cancer	5.17e-06	0.000166	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MTOR—breast cancer	5.11e-06	0.000164	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CB—breast cancer	5.11e-06	0.000164	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CXCL8—breast cancer	4.91e-06	0.000157	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—HRAS—breast cancer	4.88e-06	0.000156	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CDKN1B—breast cancer	4.79e-06	0.000154	CbGpPWpGaD
Diphenylpyraline—HRH1—GPCR downstream signaling—AKT1—breast cancer	4.74e-06	0.000152	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CASP3—breast cancer	4.7e-06	0.000151	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL2—breast cancer	4.69e-06	0.00015	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—IL6—breast cancer	4.67e-06	0.00015	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CCND1—breast cancer	4.57e-06	0.000147	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—JUN—breast cancer	4.56e-06	0.000146	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CTNNB1—breast cancer	4.53e-06	0.000145	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MMP9—breast cancer	4.44e-06	0.000142	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—CDKN1A—breast cancer	4.42e-06	0.000142	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PTEN—breast cancer	4.41e-06	0.000142	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MAPK8—breast cancer	4.32e-06	0.000138	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling by GPCR—AKT1—breast cancer	4.3e-06	0.000138	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—SRC—breast cancer	4.09e-06	0.000131	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—VEGFA—breast cancer	3.99e-06	0.000128	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—STAT3—breast cancer	3.95e-06	0.000127	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MAPK3—breast cancer	3.77e-06	0.000121	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—MYC—breast cancer	3.67e-06	0.000118	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TGFB1—breast cancer	3.66e-06	0.000117	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—EGFR—breast cancer	3.59e-06	0.000115	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—KRAS—breast cancer	3.39e-06	0.000109	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—PIK3CA—breast cancer	3.11e-06	9.99e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—TP53—breast cancer	3.01e-06	9.66e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—HRAS—breast cancer	2.88e-06	9.24e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—IL6—breast cancer	2.76e-06	8.84e-05	CbGpPWpGaD
Diphenylpyraline—HRH1—Signaling Pathways—AKT1—breast cancer	2.54e-06	8.16e-05	CbGpPWpGaD
